MRA Associates USA’s Medtronic MDT Stock Holding History

MRA Associates USA’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-211	Closed	-$20.5K	–	144
2019 Q2	$20.5K	Buy	+211	New	+$19.3K	0.08%	93

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MRA Associates USA's MDT Position: Q3 2019 in Review

MRA Associates USA sold out of Medtronic (MDT) in Q3 2019, closing a stake of 211 shares — an estimated $20.5K sold.

MRA Associates USA first reported a position in MDT in Q2 2019 and held it in 1 quarter. The position peaked at $20.5K in Q2 2019. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

MRA Associates USA reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
MRA Associates USA sold 211 Medtronic shares in Q3 2019, an estimated $20.5K.
MRA Associates USA first reported a position in Medtronic in Q2 2019 and held it in 1 quarter.
MRA Associates USA's Medtronic position peaked at $20.5K in Q2 2019.
1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on MRA Associates USA's 13F filing for Q3 2019, filed 8 Nov 2019.